Skip to main content
logo
Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.16
+0.26 (3.77%)
At close: Apr 30, 2026, 4:00 PM EDT
7.15
-0.01 (-0.14%)
After-hours: Apr 30, 2026, 4:10 PM EDT

Precision BioSciences Revenue

In the year 2025, Precision BioSciences had annual revenue of $34.26M, down -50.12%. Precision BioSciences had revenue of $34.20M in the quarter ending December 31, 2025, with 5,261.13% growth.

Revenue (ttm)
$34.26M
Revenue Growth
-50.12%
P/S Ratio
5.38
Revenue / Employee
$503,882
Employees
68
Market Cap
184.49M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202534.26M-34.43M-50.12%
Dec 31, 202468.70M19.97M40.98%
Dec 31, 202348.73M23.63M94.15%
Dec 31, 202225.10M-90.43M-78.28%
Dec 31, 2021115.53M91.24M375.72%
Dec 31, 202024.29M2.05M9.20%
Dec 31, 201922.24M11.36M104.34%
Dec 31, 201810.88M4.40M67.84%
Dec 31, 20176.48M-531.00K-7.57%
Dec 31, 20167.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MacroGenics149.50M
Protalix BioTherapeutics52.74M
Tonix Pharmaceuticals Holding13.11M
Caribou Biosciences11.16M
Korro Bio6.39M
Cartesian Therapeutics2.80M
Humacyte2.04M
Revenue Rankings

DTIL News

More News